Saturday, April 27, 2024
ADVT 
National

Canadian trial suggests benefits of remdesivir

Darpan News Desk The Canadian Press, 19 Jan, 2022 02:28 PM
  • Canadian trial suggests benefits of remdesivir

A Canadian study suggests the antiviral medication remdesivir could have a "modest but significant effect" on COVID-19 patient outcomes, including decreasing the need for mechanical ventilation by approximately 50 per cent.

The study, published Wednesday in the Canadian Medical Association Journal, is billed as the largest single-country trial of remdesivir reported to date.

Results are part of a larger study called the World Health Organization Solidarity, a randomized, controlled trial evaluating remdesivir's impact on COVID-19 patients in several countries.

Researchers at the University of British Columbia and Sunnybrook Health Sciences Centre in Toronto recruited 1,282 patients at 52 hospitals between Aug. 14, 2020 and April 1, 2021. Roughly half received a 10-day course of remdesivir while the other half got the usual level of care.

Among participants not on ventilation at the start of the study, eight per cent of the remdesivir group — 46 patients — went on to require a ventilator compared to 15 per cent, or 89 patients, who received standard care.

The study also found patients on remdesivir came off oxygen and ventilators sooner.

Evidence has been mixed on the effect of remdesivir in people with COVID-19. The World Health Organization recommended against using it to treat the virus in November 2020, saying at the time "there is currently no evidence that remdesivir improves survival and other outcomes."

Remdesivir, which is administered intravenously, is a repurposed antiviral medication originally developed to treat hepatitis C.

Dr. Robert Fowler, a senior scientist at Sunnybrook and co-author of the study, said earlier recommendations against remdesivir stemmed from premature data that didn't show a statistically significant impact on COVID-19 patients.

He said the Canadian trial results could reverse opinions on the treatment, however.

"We'll probably help a number of other countries that have similar health-care systems in terms of resources to say: 'OK. ... (remdesivir) seems it has a number of positive effects," Fowler said.

"It will probably move the needle towards people having much more confidence the medication is effective for certain outcomes."

Fowler said he expects the WHO to release results from the Solidarity trial's other participating nations within the next couple of months.

The Canadian arm, funded by the Canadian Institutes of Health Research, collected more detailed data than some other countries and included patients across a range of ethnicities.

The study also looked at in-hospital mortality, which was slightly lower in the remdesivir group at 18.7 per cent, compared to 22.6 in the control group. Fowler said those figures weren't statistically significant "in absolute terms."

While the study period ended before Omicron arrived in Canada, Fowler said remdesivir is likely to have the same effect on those hospitalized with the variant.

He added that effective COVID-19 treatments are critical at this stage of the pandemic as soaring case counts have overwhelmed health-care systems across the country.

Publication of the study came two days after Health Canada authorized use of the take-home Pfizer antiviral pill Paxlovid, meant to reduce hospitalizations in those at higher risk of severe COVID-19 disease.

"It becomes critical that your next line of treatments are effective and growing," Fowler said.

"I would say, luckily, and with a lot of hard work behind it, there are an increasing number of medications, this one included ... to help patients survive and to get out of hospital sooner."

 

MORE National ARTICLES

B.C. nurses, doctors burnt out as COVID peak nears

B.C. nurses, doctors burnt out as COVID peak nears
While the most challenging days of COVID-19 are predicted to be ahead for British Columbia’s health-care system, representatives for doctors and nurses say their members are on the verge of a possible collapse. Doctors of BC president Dr. Ramneek Dosanjh said it has been an overwhelming three years for her members.    

B.C. nurses, doctors burnt out as COVID peak nears

COVID-19 restrictions extended in B.C.

COVID-19 restrictions extended in B.C.
That's when restrictions were set to expire, but Dr. Bonnie Henry said last week that they believed COVID-19 hospitalizations were expected to spike after cases within the community had peaked.

COVID-19 restrictions extended in B.C.

5,625 COVID19 cases over 3 days

5,625 COVID19 cases over 3 days
There are 35,985 active cases of COVID-19 in the province, and 257,677 people who tested positive have recovered. Of the active cases, 819 COVID-positive individuals are in hospital and 99 are in intensive care. The remaining people are recovering at home in self-isolation.

5,625 COVID19 cases over 3 days

Scientists study meteorite that landed in B.C.

Scientists study meteorite that landed in B.C.
The small meteorite broke through a woman's ceiling in Golden, B.C., in October, landing on her pillow, next to where she had been sleeping moments earlier.

Scientists study meteorite that landed in B.C.

B.C. Premier Horgan completes cancer treatment

B.C. Premier Horgan completes cancer treatment
Horgan posted the update on Twitter, saying he is "so grateful" for the compassion and professionalism of the BC Cancer team and health workers across the province who are under incredible strain right now.

B.C. Premier Horgan completes cancer treatment

Fish processing plant to close in Surrey, B.C.

Fish processing plant to close in Surrey, B.C.
Fisheries Minister Joyce Murray could not immediately be reached for comment but said last month she plans to ensure the decision to phase out 19 open-net pen farms from the Discovery Islands is carried on to completion.

Fish processing plant to close in Surrey, B.C.